Literature DB >> 19672630

Management patterns of childhood-onset nephrotic syndrome.

Nathaniel MacHardy1, Paul V Miles, Susan F Massengill, William E Smoyer, John D Mahan, Larry Greenbaum, Sara Massie, Lynne Yao, Shashi Nagaraj, Jen-Jar Lin, Delbert Wigfall, Howard Trachtman, Yichun Hu, Debbie S Gipson.   

Abstract

As an initial effort to identify opportunities to improve the management of children with nephrotic syndrome, the goal of this study was to assess the present-day management of children with primary nephrotic syndrome. A web-based survey was designed to assess the current management styles of all pediatric nephrology faculties at ten participating institutions. Ninety-one percent completed the initial survey. The duration of initial glucocorticoid therapy ranged from 4 to 24 weeks. Physicians reported that the recommendation for kidney biopsy was dependent on the response to initial corticosteroid therapy, with the minority always recommending a biopsy for frequently relapsing or steroid-dependent cases. All responding physicians recommended a kidney biopsy in steroid-resistant cases. Treatment strategies were reported to vary based upon the steroid response pattern and, where available, kidney histopathology. Striking variations in therapeutic preferences were described when alternatives to glucocorticoids were considered. The variability of management practices among pediatric nephrologists in the USA combined with the changing characteristics of our pediatric population raise concerns about our future strategies for improving healthcare for children coping with nephrotic syndrome. This variability is not unique to children's healthcare or to nephrology. However, a systematic approach to patient care and improvement in health outcomes has been shown to substantially improve morbidity and mortality outcomes in children with chronic health conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672630     DOI: 10.1007/s00467-009-1282-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Variability among pediatric nephrologists in the initial therapy of nephrotic syndrome.

Authors:  M B Lande; M B Leonard
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

2.  Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.

Authors:  M J Gregory; W E Smoyer; A Sedman; D B Kershaw; R P Valentini; K Johnson; T E Bunchman
Journal:  J Am Soc Nephrol       Date:  1996-04       Impact factor: 10.121

Review 3.  Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.

Authors:  A Fagot-Campagna; D J Pettitt; M M Engelgau; N R Burrows; L S Geiss; R Valdez; G L Beckles; J Saaddine; E W Gregg; D F Williamson; K M Narayan
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

4.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

5.  A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.

Authors:  Masahiro Hiraoka; Hirokazu Tsukahara; Kousaku Matsubara; Masahito Tsurusawa; Nobuaki Takeda; Shinichi Haruki; Shuhei Hayashi; Kazuhide Ohta; Tohru Momoi; Yusei Ohshima; Narufumi Suganuma; Mitsufumi Mayumi
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

6.  Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis.

Authors:  J M Sorof; E P Hawkins; E D Brewer; I I Boydstun; A S Kale; D R Powell
Journal:  Pediatr Nephrol       Date:  1998-11       Impact factor: 3.714

7.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Kidney Dis       Date:  1985-08       Impact factor: 8.860

Review 8.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  E M Hodson; N S Willis; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie".

Authors: 
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  29 in total

1.  Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome.

Authors:  Shuichi Ito; Hirokazu Ikeda; Tomonori Harada; Koichi Kamei; Eihiko Takahashi
Journal:  Pediatr Nephrol       Date:  2011-06-28       Impact factor: 3.714

Review 2.  New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

Authors:  Michael van Husen; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-01-13       Impact factor: 3.714

3.  Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.

Authors:  Véronique Baudouin; Corinne Alberti; Anne-Laure Lapeyraque; Albert Bensman; Jean-Luc André; Françoise Broux; Mathilde Cailliez; Stéphane Decramer; Patrick Niaudet; Georges Deschênes; Evelyne Jacqz-Aigrain; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2011-09-28       Impact factor: 3.714

Review 4.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

Review 5.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

6.  Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?

Authors:  Sermin A Saadeh; Rossana Baracco; Amrish Jain; Gaurav Kapur; Tej K Mattoo; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

7.  Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable?

Authors:  Shuichiro Fujinaga; Amane Endo; Yoshiyuki Ohtomo; Yoshikazu Ohtsuka; Toshiaki Shimizu
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

8.  Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.

Authors:  Nynke Teeninga; Joana E Kist-van Holthe; Nienske van Rijswijk; Nienke I de Mos; Wim C J Hop; Jack F M Wetzels; Albert J van der Heijden; Jeroen Nauta
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

9.  Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers.

Authors:  Susan M Samuel; Rachel Flynn; Michael Zappitelli; Allison Dart; Rulan Parekh; Maury Pinsk; Cherry Mammen; Andrew Wade; Shannon D Scott
Journal:  CMAJ Open       Date:  2017-06-07

10.  Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.

Authors:  Koichi Nakanishi; Kazumoto Iijima; Kenji Ishikura; Hiroshi Hataya; Hitoshi Nakazato; Satoshi Sasaki; Masataka Honda; Norishige Yoshikawa
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.